LT2827860T - Pirazolo darinio panaudojimas stiprių lėtinės obstrukcinės plaučių ligos paūmėjimų gydymui - Google Patents
Pirazolo darinio panaudojimas stiprių lėtinės obstrukcinės plaučių ligos paūmėjimų gydymuiInfo
- Publication number
- LT2827860T LT2827860T LTEP13710851.0T LT13710851T LT2827860T LT 2827860 T LT2827860 T LT 2827860T LT 13710851 T LT13710851 T LT 13710851T LT 2827860 T LT2827860 T LT 2827860T
- Authority
- LT
- Lithuania
- Prior art keywords
- treatment
- pulmonary disease
- chronic obstructive
- obstructive pulmonary
- pyrazole derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261613187P | 2012-03-20 | 2012-03-20 | |
| PCT/EP2013/055730 WO2013139809A1 (en) | 2012-03-20 | 2013-03-19 | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2827860T true LT2827860T (lt) | 2016-12-12 |
Family
ID=47901996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP13710851.0T LT2827860T (lt) | 2012-03-20 | 2013-03-19 | Pirazolo darinio panaudojimas stiprių lėtinės obstrukcinės plaučių ligos paūmėjimų gydymui |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US9339491B2 (lt) |
| EP (1) | EP2827860B1 (lt) |
| JP (1) | JP6091593B2 (lt) |
| KR (1) | KR101793777B1 (lt) |
| CN (1) | CN104203234B (lt) |
| AU (1) | AU2013237503B2 (lt) |
| BR (1) | BR112014023107B1 (lt) |
| CA (1) | CA2866108C (lt) |
| CL (1) | CL2014002471A1 (lt) |
| CY (1) | CY1118327T1 (lt) |
| DK (1) | DK2827860T3 (lt) |
| ES (1) | ES2605942T3 (lt) |
| HK (1) | HK1200352A1 (lt) |
| HR (1) | HRP20161514T1 (lt) |
| HU (1) | HUE032004T2 (lt) |
| IL (1) | IL234537A (lt) |
| LT (1) | LT2827860T (lt) |
| MA (1) | MA37455B1 (lt) |
| MX (1) | MX351996B (lt) |
| NZ (1) | NZ628392A (lt) |
| PH (1) | PH12014502107A1 (lt) |
| PL (1) | PL2827860T3 (lt) |
| PT (1) | PT2827860T (lt) |
| RU (1) | RU2625762C2 (lt) |
| SG (1) | SG11201404941WA (lt) |
| SI (1) | SI2827860T1 (lt) |
| TN (1) | TN2014000350A1 (lt) |
| TW (1) | TWI583381B (lt) |
| WO (1) | WO2013139809A1 (lt) |
| ZA (1) | ZA201405871B (lt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2600833C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронической обструктивной болезни легких |
| RU2600822C1 (ru) * | 2015-09-03 | 2016-10-27 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГБУ "РНЦРХТ" Минздрава России) | Способ лечения хронического обструктивного бронхита |
| CA3016488C (en) | 2016-03-08 | 2023-04-11 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| WO2017153701A1 (en) * | 2016-03-08 | 2017-09-14 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
| US10331542B2 (en) * | 2016-06-23 | 2019-06-25 | International Business Machines Corporation | System and method for detecting and alerting unexpected behavior of software applications |
| GB201612238D0 (en) * | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
| GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
| CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| HUE054266T2 (hu) | 2017-12-11 | 2021-08-30 | Mereo Biopharma 1 Ltd | 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciklopropil-4-metilbenzamid alkalmazása krónikus obstruktív tüdõbetegség akut megjelenésének megelõzésében |
| EP3585382B1 (en) | 2017-12-11 | 2021-07-14 | Mereo BioPharma 1 Limited | Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI452035B (zh) * | 2003-06-26 | 2014-09-11 | Novartis Ag | 以５員雜環為主之ｐ３８激酶抑制劑 |
| GB0603684D0 (en) | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
-
2013
- 2013-03-19 NZ NZ628392A patent/NZ628392A/en unknown
- 2013-03-19 CN CN201380015703.5A patent/CN104203234B/zh active Active
- 2013-03-19 RU RU2014141893A patent/RU2625762C2/ru active
- 2013-03-19 BR BR112014023107-9A patent/BR112014023107B1/pt active IP Right Grant
- 2013-03-19 DK DK13710851.0T patent/DK2827860T3/en active
- 2013-03-19 US US14/386,174 patent/US9339491B2/en active Active
- 2013-03-19 SG SG11201404941WA patent/SG11201404941WA/en unknown
- 2013-03-19 LT LTEP13710851.0T patent/LT2827860T/lt unknown
- 2013-03-19 MA MA37455A patent/MA37455B1/fr unknown
- 2013-03-19 AU AU2013237503A patent/AU2013237503B2/en active Active
- 2013-03-19 TW TW102109739A patent/TWI583381B/zh active
- 2013-03-19 KR KR1020147025904A patent/KR101793777B1/ko active IP Right Grant
- 2013-03-19 EP EP13710851.0A patent/EP2827860B1/en active Active
- 2013-03-19 ES ES13710851.0T patent/ES2605942T3/es active Active
- 2013-03-19 HU HUE13710851A patent/HUE032004T2/en unknown
- 2013-03-19 JP JP2015500892A patent/JP6091593B2/ja active Active
- 2013-03-19 MX MX2014011291A patent/MX351996B/es active IP Right Grant
- 2013-03-19 PL PL13710851T patent/PL2827860T3/pl unknown
- 2013-03-19 CA CA2866108A patent/CA2866108C/en active Active
- 2013-03-19 SI SI201330397A patent/SI2827860T1/sl unknown
- 2013-03-19 PT PT137108510T patent/PT2827860T/pt unknown
- 2013-03-19 WO PCT/EP2013/055730 patent/WO2013139809A1/en active Application Filing
-
2014
- 2014-08-11 TN TNP2014000350A patent/TN2014000350A1/fr unknown
- 2014-08-11 ZA ZA2014/05871A patent/ZA201405871B/en unknown
- 2014-09-08 IL IL234537A patent/IL234537A/en active IP Right Grant
- 2014-09-17 CL CL2014002471A patent/CL2014002471A1/es unknown
- 2014-09-22 PH PH12014502107A patent/PH12014502107A1/en unknown
-
2015
- 2015-01-29 HK HK15101000.9A patent/HK1200352A1/zh unknown
-
2016
- 2016-04-29 US US15/143,356 patent/US20160243081A1/en not_active Abandoned
- 2016-11-16 HR HRP20161514TT patent/HRP20161514T1/hr unknown
- 2016-11-18 CY CY20161101194T patent/CY1118327T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1200352A1 (zh) | 吡唑衍生物用於治療慢性阻塞性肺病急性惡化的用途 | |
| IL285843A (en) | Ibrutinib for use in the treatment of graft-versus-host disease | |
| HK1211844A1 (en) | Treatment of pulmonary disease | |
| HK1198556A1 (en) | Prediction of outcome in patients with chronic obstructive pulmonary disease | |
| GB2512799B (en) | Transaction begin/end instructions | |
| SI2845593T1 (sl) | Piridinski in pirazinski derivat za zdravljenje kronične obstruktivne pljučne bolezni | |
| EP2925382A4 (en) | AMBULATORY AND EXTRACORPORAL ASSISTANCE PUNGON | |
| HK1204773A1 (en) | Pyrazole derivative and use thereof for medical purposes | |
| EP2913047A4 (en) | SPECIFIC THERAPEUTIC AGENT OF PULMONARY DISEASE | |
| GB201109524D0 (en) | Transaction authorisation | |
| HK1197297A1 (en) | Ros kinase in lung cancer ros | |
| EP2840938A4 (en) | THERAPEUTIC CUSHION | |
| HK1206714A1 (en) | Triazole carboxamide derivatives | |
| SG11201601807XA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| GB201116238D0 (en) | A process for assisting in the design of room layouts | |
| EP2826479A4 (en) | TREATMENT AGENT FOR CHRONIC-OBSTRUCTIVE LUNG DISEASE | |
| GB201217330D0 (en) | Therapeutic for treating inflammatory lung disorders | |
| EP2823818A4 (en) | USE OF RUPATADINE IN THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OBSTRUCTIVE CHRONIC BRONCHOPNEUMOPATHY | |
| PL2861568T3 (pl) | Aminy trzeciorzędowe do zastosowania w leczeniu zaburzeń serca | |
| EP2817004A4 (en) | BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES | |
| PL2709584T3 (pl) | Zastosowanie sensoryczne pochodnych 6-cyklopentylidenoheksanu | |
| IL233568A0 (en) | A method for treating obstructive lung disease | |
| TH1401005467B (th) | การใช้อนุพันธ์ไพราโซลในการรักษาการกำเริบแบบเฉียบพลันของโรคปอดอุดกั้นชนิดเรื้อรัง | |
| TH148366B (th) | การใช้อนุพันธ์ไพราโซลในการรักษาการกำเริบแบบเฉียบพลัน ของโรคปอดอุดกั้นชนิดเรื้อรัง | |
| ZA201505093B (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis |